Pharmacogenomics and Psychiatric Clinical Care
| Autor: | Lauren R. Few, Joseph Boland, Russell J Amato, Nicole Myer, Daniel Dowd |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty MEDLINE Psychiatric Nursing 03 medical and health sciences 0302 clinical medicine Quality of life (healthcare) Health care Medicine Humans Psychiatry General Nursing Genetic testing medicine.diagnostic_test business.industry Mental Disorders Mental health United States Clinical trial Psychotherapy 030104 developmental biology Pharmacogenetics Pharmacogenomics Quality of Life Pshychiatric Mental Health business Psychosocial 030217 neurology & neurosurgery |
| Zdroj: | Journal of psychosocial nursing and mental health services. 56(1) |
| ISSN: | 0279-3695 |
| Popis: | Approximately one in five individuals in the United States experiences mental health issues in any given year, and these disorders are consistently among the leading causes of years lived with disability. Unfortunately, many mental illnesses are lifelong conditions that require medication and therapy to improve quality of life, yet clinical trial data show that many patients fail to achieve remission or require several pharmacological interventions prior to remission. These results indicate a need to address the variability among patients in their response to medication, in addition to developing treatment plans tailored to the individual. One approach that may help explain patient variability in response to medication is pharmacogenetic testing. The current review shows the clinical use of pharmacogenetic testing in a small subset of gene variants and how they pertain to psychiatric illness and treatment. Recent evidence suggests that genetic testing for psychiatric illness can improve patient outcomes in addition to decreasing health care costs. [ Journal of Psychosocial Nursing and Mental Health Services, 56 (1), 22–31.] |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|